The G558R mutation of RasGRP3 detected in a colon cancer patient indicates that RasGRP3 may be associated with inflammation-related diseases, which may need validations in clinical samples derived from patients with SLE, RA or IBD. This evidence concerns the gene RASGRP3 and systemic lupus erythematosus.